Table 1 Baseline characteristics of the patients
All patients (n = 103) | |
|---|---|
Age (years) | 58 ± 17 |
Gender male/female, n/(%) | 65 (63.1)/38 (36.9) |
APACHE II score | 26 ± 7 |
SOFA score | 9 ± 4 |
Hemoglobin (g/dl) | 10.3 ± 1.9 |
Presence of severe sepsis | |
Yes, n (%) | 48 (46.6) |
No, n (%) | 55 (53.4) |
Cardiogenic, n (%) | 50 (48.5) |
Vasoactive drug use | |
None, n (%) | 41 (40) |
Vasopressors, n (%) | 33 (32) |
Norepinephrine | 20 (19) |
Dopamine | 5 (5) |
Inotropes, n (%) | 29 (28) |
Dobutamine | 17 (17) |
Milrinone | 5 (5) |
Levosimendan | 2 (2) |
Vasoactive dose | |
Norepinephrine, μg/kg/min | 0.1 ± 0.1 |
Dopamine, μg/kg/min | 5.2 ± 2.6 |
Dobutamine, μg/kg/min | 4.6 ± 1.9 |
Milrinone, μg/kg/min | 0.42 ± 0.21 |
Levosimendan, μg/kg/min | 0.2 ± 0.1 |